Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|1|50-56

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.1, 2015-07, pp. : 50-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1656-1662

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Limited Significance of a Longer Duration of Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy for High-Risk Prostate Cancer in Japanese Men

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

Predicting pathological outcomes in patients undergoing robot‐assisted radical prostatectomy for high‐risk prostate cancer: a preoperative nomogram

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 703-712

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting pathological outcomes in patients undergoing robot‐assisted radical prostatectomy for high‐risk prostate cancer: a preoperative nomogram

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 703-712

John Wiley & Sons Inc

Access to resources Recommend Favorite